Parametric Sound Corporation Reports Second Quarter Fiscal

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Parametric Sound Corporation Reports Second Quarter Fiscal 2013 Financial Results

SAN DIEGO, CA--(Marketwired - May 2, 2013) - Parametric Sound Corporation ( NASDAQ : PAMT ), a leading innovator of audio technology and solutions, today announced financial results for its second fiscal quarter ended March 31, 2013. The Company also reported progress in each of its business sectors: commercial, consumer and health applications. Discussions with companies interested in pursuing strategic options beyond licensing are progressing.

Recent Highlights:

  • Assessing strategic alternatives - As previously announced, the Company has been approached by several industry leaders in key target verticals to discuss strategic alternatives for its HyperSound™ (HSS) technology. It has engaged the investment bank Houlihan Lokey to help assess the opportunities. The Company has received a term sheet from a leader in one of its target verticals and is now undergoing due diligence. The Company has also received and is evaluating strategic inquiries from additional parties.
  • Licensing progress - The Company has received substantial licensing proposals for its technology but is first assessing broader strategic opportunities.
  • Progress with commercial pilot projects - The Company grew its commercial product pipeline and several pilots are expanding based on successful results. Global demand is expected to produce broad-based rollouts during the balance of 2013 and 2014.
  • Bolstered intellectual property with new patent application - The Company filed for patent protection on novel new emitter technology that it believes will expand the applications for its directional and 3D audio systems. The new technology allows for performance enhancements and costs savings, as well as the ability to more easily shape various form factors to fit the requirements of multiple new applications for directed audio. 
  • Strategic relationship with manufacturing and distribution partner - The Company signed a memorandum of understanding to enter into a strategic relationship with Shanghai Industrial Investment Group (SIIG) and Aviation Industry Corporation's (AVIC) US trade representative, Optek Electronics. The MOU defines four key areas of focus that include a licensing agreement, a manufacturing agreement, a joint product development agreement, and the establishment of a joint venture to address the Chinese market across business sectors.
  • Collaboration proceeding to investigate health applications - The Company's collaboration with the California Hearing & Balance Center is progressing as the Company investigates health applications of its technology. Preference testing using the Company's HSS sound technology side-by-side with traditional audio continues to indicate that a broad range of listeners identify improved clarity and comprehension of HSS. The Company believes its technology may provide benefits by delivering with clarity the frequencies important in speech recognition, thus improving the listening experience of those with normal hearing, and by providing amplification for those with some hearing loss without the need for headphones.

Management Commentary:

"We have received a term sheet and have entered into due diligence with a market leader in one of our target verticals. We have also received additional strategic inquiries from other parties," said Kenneth Potashner, executive chairman. "We have demonstrated solid operational progress with our pilot commercial projects. We have been awarded a volume rollout in one of our initial pilots, have been asked to expand several other pilots, and are also actively initiating new relationships. We continue to collect data relative to the benefits that our technology can bring to those with hearing challenges and are optimistic on the potential for this application."

Second Quarter Fiscal 2013 Financial Summary:

Revenue totaled $155,000 during the second quarter of fiscal 2013, as compared to $60,000 during the same period last year, reflecting an increase in commercial product sales. Order backlog was $30,000 at March 31, 2013. Gross profit was $76,000 compared to $33,000 for the prior year.

Selling, general and administrative expenses during the second quarter of fiscal 2013 totaled $1.4 million as compared to $726,000 during the same period last year. Second quarter expense included non-cash stock based compensation from stock options of $695,000 compared to $284,000 for the prior year. Other selling, general and administrative costs increased as the Company added executive management and increased staffing related to its licensing initiative. The Company also invested in developing commercial distributors and new customers focusing on larger volume applications that are expected to contribute to improved cash flow during fiscal 2013.

Research and development expenses totaled $588,000 during the second quarter of fiscal 2013 including stock option expense of $95,000. Research and development expenses during the second quarter of fiscal 2012 were $267,000 including $79,000 of stock option expense. The increase was primarily the result of adding employees to support technology development and costs associated with prototypes and testing for licensing initiatives.

Net loss for the second quarter of fiscal 2013 was $2.0 million, or $(0.30) per basic and diluted common share, as compared to a net loss of $961,000, or $(0.22) per basic and diluted common share for the same quarter last year. The net loss for the second quarters of fiscal 2013 and 2012 included $790,000 and $363,000 of non-cash stock based compensation expense, respectively.

Cash and cash equivalents totaled $3.8 million at March 31, 2013, compared to $4.6 million at December 31, 2012. Subsequent to March 31, 2013 the Company received $439,000 in cash from the exercise of stock purchase warrants.

Conference Call Information:

Members of the Company's management team will host a conference call at 5:00 P.M. ET today to discuss the Company's financial results. Investors and interested parties may participate in the call by dialing (877) 303-9855 and referring to Conference ID: 34032818. It is suggested that you dial into the conference center approximately 10 minutes prior to the scheduled start time to ensure that all participants are on line at the start of the call. The conference call is also being webcast and is available via the investor relations section of the Company's website, www.parametricsound.com . A replay of the webcast will be archived on the Company's website for 60 days.

About Parametric Sound Corporation

Parametric Sound Corporation is a pioneering innovator of directed audio solutions. With a substantial body of intellectual property, Parametric Sound is the foremost authority in the application of acoustic technology to beam sound to target a specific listening area without the ambient noise of traditional speakers. Distinct from surround sound, HyperSound™ immerses listeners in a robust 3D audio experience from just two speakers. The Company's disruptive technology is being marketed to three global market sectors: Consumer Markets -- for PCs, gaming, TVs, home theater and handhelds, Commercial Markets -- for digital signage, kiosks and retail stores, and Health Care -- for an out-of-ear solution being developed for the hearing impaired. For more information, visit www.parametricsound.com .

Cautionary note on forward-looking statements

This press release includes forward-looking information and statements. Except for historical information contained in this release, statements in this release may constitute forward-looking statements regarding assumptions, projections, expectations, targets, intentions or beliefs about future events that are based on management's belief, as well as assumptions made by, and information currently available to, management. While the Company believes that its expectations are based upon reasonable assumptions, there can be no assurances that its goals and strategy will be realized. Numerous factors, including risks and uncertainties, may affect actual results and may cause results to differ materially from those expressed in forward-looking statements made by the Company or on its behalf. Some of these factors include the substantial uncertainties inherent in evaluating, pursuing and finalizing strategic discussions including, but not limited to, licensing, mergers, joint ventures, spin-offs or other corporate transactions, acceptance of existing and future products regardless of initial pilot successes or positive end-user feedback, the difficulty of commercializing and protecting new technology such as the Company's new emitter technology, the impact of competitive products and pricing, general business and economic conditions, and other factors detailed in the Company's Annual Report on Form 10-K and other periodic reports filed with the SEC. The Company specifically disclaims any obligation to update or revise any forward-looking statement whether as a result of new information, future developments or otherwise.

 
Parametric Sound Corporation
Condensed Consolidated Balance Sheets
(000's omitted except per share amount)
(unaudited)
    March 31,   September 30,
    2013   2012
    $   $
ASSETS        
  Current        
    Cash   3,823   5,528
    Accounts receivable   107   39
    Inventories, net   399   443
    Prepaid expenses and other current assets   141   63
  Total current assets   4,470   6,073
  Property, equipment and tooling, net   286   177
  Intangible assets , net   1,351   1,315
  Total assets   6,107   7,565
         
LIABILITIES AND STOCKHOLDERS' EQUITY        
  Current        
    Accounts payable   327   173
    Accrued liabilities   105   140
    Capital lease obligation - current   37   -
  Total current liabilities   469   313
  Long-term capital lease obligation   114   -
  Total liabilities   583   313
  Stockholders' equity   5,524   7,252
  Total liabilities and stockholders' equity   6,107   7,565
         
         
                     
Parametric Sound Corporation
Condensed Consolidated Statements of Operations
(000's omitted except per share amount)
(unaudited)
           
    For the three months     For the six months
    ended March 31,     ended March 31,
    2013     2012     2013   2012
    $     $     $   $
Revenues   155     60     264   124
Cost of revenues   79     27     133   52
  Gross profit   76     33     131   72
Operating expenses: (i)                    
  Selling, general and administrative   1,444     726     2,360   1,065
  Research and development   588     267     980   498
Total operating expenses   2,032     993     3,340   1,563
Loss from operations   (1,956 )   (960 )   (3,209)   (1,491)
Other income (expenses)   -     (1 )   2   (2)
Net loss   (1,956 )   (961 )   (3,207)   (1,493)
Loss per basic and diluted common share   (0.30 )   (0.22 )   (0.50)   (0.36)
                     
Weighted average shares used to compute net loss per basic and diluted common share   6,435     4,386     6,422   4,148
                     
(i) includes share-based compensation expense as follows:
           
    For the three months     For the three months
    ended March 31,     ended March 31,
    2013     2012     2013   2012
Selling, general and administrative   695     284     886   437
Research and development   95     79     158   123
  Total share-based compensation expense   790     363     1,044   560
                       

CONTACT: Tracy Neumann 888-HSS-2150, Ext. 509 tneumann@parametricsound.com INVESTOR RELATIONS CONTACT: Dave Mossberg Three Part Advisors, LLC (817) 310-0051

Scroll down for more posts ▼

Top 10 Most Recent News Articles

US Myeloma Network Revolutionizes Cancer Trials in U.S.

Updated Category News Views 7

New Era for Myeloma Research In a move set to shake up the oncology world, the International Myeloma Foundation (IMF) is lighting a fire under clinical research with its ambitious US Myeloma Network (USMN). The whole shebang is about supercharging clinical trials and bringing real hope to folks battling multiple myeloma. If you've been watching the space, you know we're...

Continue Reading
CHERY Unveils New SUVs: A Family-Centric Approach

Updated Category News Views 8

Expanding the Family Focus at CHERY Brand Night When I saw the splash that CHERY Auto made at their Brand Night in Wuhu, Anhui, I had to take a moment. It wasn't just about unveiling the All-New TIGGO7 and the TIGGOX7, but a whole philosophy geared towards families and their ever-shifting needs. Now, they didn't skimp on the fanfare—inviting families from places like...

Continue Reading
Amynta's Southern States Deal: A Strategic Move?

Updated Category News Views 0

Digging Into Amynta's Latest Acquisition Alright, pull up a stool because Amynta Group just wrapped up a deal that could stir up the insurance pot a little. They snagged Southern States Underwriters, a specialty managing general underwriter focusing on commercial property and casualty insurance for the agribusiness sector. With this acquisition, Amynta doesn't just...

Continue Reading
LifeWave's Bold New Path in Human Performance

Updated Category News Views 4

Redefining the Everyday Athlete Not every day you see a wellness company talking about 'performance' in the broader human sense. Not just for the pros or those beating personal records but for anyone looking to lift the quality of their daily grind. That's the new line LifeWave's drawing in the sand with their spiffy 'Human Performance Technology.' They're looking to...

Continue Reading
Kahn Swick & Foti Questions Valaris Transocean Deal

Updated Category News Views 0

Valaris and Transocean: A Closer Look at the Deal Diving right into it, folks, we've got Kahn Swick & Foti, LLC taking a hard look at the proposed sale of Valaris Limited over to Transocean Ltd. Now, on paper, this might seem like another run-of-the-mill corporate shuffle, but not so fast. There're a few rocky waters here that might make even the hardest boiled of us...

Continue Reading
Giese Foundation Boosts Cancer Support Services Reach

Updated Category News Views 2

When cancer pays an unwelcome visit to a family, it doesn’t come alone. It drags along fear, uncertainty, and bruising challenges. And as support needs balloon, thankfully there's a beacon like the Brian & Patricia Giese Foundation stepping up to sustain vital programs. Understanding the Real Impact Now, listen up. Cancer may target one body, but its claws reach...

Continue Reading
Lennox-Gastaut Syndrome: Unseen Struggles and Hope Ahead

Updated Category News Views 2

Asking the World to See LGS Life throws curveballs, but Lennox-Gastaut Syndrome (LGS) comes barreling down like a freight train in the quiet. It's a rare form of epilepsy that sows chaos in young lives with relentless seizures, leaving families in a fog of uncertainty and heartbreak for years. On International LGS Awareness Day™, November 1, families and advocates are...

Continue Reading
Sustainability Conference Gathers Leaders in Shanghai

Updated Category News Views 6

Shanghai's Moment as a Global Sustainability Hub Shanghai's not pulling any punches, hosting a heavyweight gathering of global leaders, thinkers, and innovators with their eyes set on the prize: a sustainable future. As the 2026 Sustainability Global Leaders Conference unfolds in the bustling Huangpu district from October 20 to 22, more than 300 top-tier minds will churn...

Continue Reading
BRG Communications Bolsters Leadership to Fuel Growth

Updated Category News Views 2

New Faces, Fresh Perspectives at BRG BRG Communications is upping the ante, folks. As they toast to their 25th year in the biz, this healthcare PR outfit isn't just resting on its laurels. Nope, four big guns just joined their ranks — Caitlin Chase, Leanne Stone, Brandon Kenah, and Vijaya Singh. These additions aren't just for show; they bring a heap of expertise that...

Continue Reading
Veterinary Industry Could Unlock Growth by Empowering Technicians

Updated Category News Views 6

Doors Not Fully Open for Vet Technicians Here's the skinny: the vet industry’s sitting on a goldmine of untapped potential right under its nose. According to a fresh study by Penn Foster, there's a glaring disconnect between what vet techs are trained to handle and what they're actually allowed to do in practice. If practices start trusting these pros to do their thing,...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched by Robbins Geller into Stride, Inc. (LRN)

Updated Category News Views 171

Investigation into Stride, Inc. by Robbins Geller Rudman & Dowd LLP The esteemed law firm of Robbins Geller Rudman & Dowd LLP is proactively investigating compliance issues surrounding Stride, Inc. (NYSE: LRN). This inquiry seeks to examine if Stride or some of its executives have engaged in misleading practices regarding federal securities laws. Through this...

Continue Reading
Municipality Finance Successfully Redeems Notes and Shifts Focus

Updated Category News Views 99

Municipality Finance Moves to Redeem Notes from Trading Municipality Finance Plc has taken significant steps in its financial operations, recently announcing the redemption of its EUR 10 million notes. This strategic move indicates the company's proactive approach to managing its financial resources effectively. Redemption Process and Trading Suspension On 1 November...

Continue Reading
Exploring the Benefits of Barefoot Hiking and Gear

Updated Category News Views 240

Embracing Barefoot Hiking: A New Trend As the cooler days of fall approach, hiking enthusiasts are getting excited for the shifting landscapes and invigorating outdoor experiences. One of the most talked-about trends in recent years is barefoot hiking, which advocates for a more primal connection with nature. What is Barefoot Hiking? Barefoot hiking can refer to either...

Continue Reading
BiomX to Share Promising Phase 1b/2a Data for BX004

Updated Category News Views 76

BiomX to Present Encouraging Phase 1b/2a Data for BX004 BiomX Inc. (NYSE American: PHGE), a pioneer in innovative phage therapies targeting harmful bacteria, is set to reveal positive results from its Phase 1b/2a trial of BX004. This study focuses on cystic fibrosis (CF) patients who struggle with chronic lung infections. This important update will be unveiled at the...

Continue Reading
Berkshire Hills Bancorp Plans Earnings for Q2 2025

Updated Category News Views 136

Upcoming Earnings Release for Berkshire Hills Bancorp Berkshire Hills Bancorp, Inc. (NYSE: BHLB) has exciting news regarding its second quarter earnings release and corresponding conference call. The details have been set, and stakeholders can mark their calendars to stay updated on the company’s performance. Details for Earnings Call The earnings release is scheduled...

Continue Reading